Drugs / Moclobemide
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT03010761 | Jan 2016 → Jan 2018 | substance dependence | China Medical University Hospital | Terminated | No outcome recorded |
| Phase 2 | NCT01926626 | Sep 2013 → Jul 2014 | nicotine dependence | Jed E. Rose | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00534573 Comparator | Nov 2008 → Jan 2009 | — | Beersheva Mental Health Center | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moclobemide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00534573 ↗ |
| Known as | Aurorix | ChEMBL registry synonym — accepted as the source's own label CHEMBL86304 ↗ |
| Known as | GNF-PF-695 | ChEMBL registry synonym — accepted as the source's own label CHEMBL86304 ↗ |
| Known as | Manerix | ChEMBL registry synonym — accepted as the source's own label CHEMBL86304 ↗ |
| Known as | Moclobemida | ChEMBL registry synonym — accepted as the source's own label CHEMBL86304 ↗ |
| Known as | RO 11-1163/000 | ChEMBL registry synonym — accepted as the source's own label CHEMBL86304 ↗ |
| Action | Inhibit | “moclobemide, a selective, reversible MAO-A inhibitor” NCT01926626 ↗1“Monoamine oxidase A inhibitor” CHEMBL86304 ↗ |
| Modality | Small molecule | — CHEMBL86304 ↗ |
| Target | MAOA | “Monoamine oxidase A inhibitor” CHEMBL86304 ↗ |